Index to Volume 21 Author Index A Abbass A (see de Maat S et al.). 107–137 (Review) Ablon JS (see Pollastri AR et al.). 188–199 (Perspectives) Ablon S (see Greene DI et al.). 259–268 (Clinical Challenge) Asih H (see Desseilles M et al.). 269–274 (Psychopharmacology) Azar A (see Ravven S et al.). 59–69 (Review)
B Baca-Garcia E (see Mendez-Bustos P et al.). 281–295 (Review) Bader C (see Ravven S et al.). 59–69 (Review) Bagot KS (see Ugochukwu C et al.). 1–17 (Review) Bailey RC, Grenyer BFS. Burden and Support Needs of Carers of Persons with Borderline Personality Disorder: A Systematic Review. 248–258 (Review) Barber JP (see de Maat S et al.). 107–137 (Review) Barrett MS (see Johnson RA et al.). 334–344 (Perspectives) Baslet G (see Chudleigh C et al.). 163–174 (Clinical Challenge) Baxter H (see Chudleigh C et al.). 163–174 (Clinical Challenge) Betancourt TS, Meyers-Ohki SE, Charrow AP, Tol WA. Interventions for Children Affected by War: An Ecological Perspective on Psychosocial Support and Mental Health Care. 70–91 (Review) Biswas J, Chu JA, Perez DL, Gutheil TG. From the Neuropsychiatric to the Analytic: Three Perspectives on Dissociative Identity Disorder. 41–51 (Clinical Challenge) Bizik G, Picard M, Nijjar R, Tourjman V, McEwen BS, Lupien SJ, Juster R-P. Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses. 296–313 (Review) Blumenthal-Barby JS, McCullough LB, Krieger H, Coverdale J. Methods of Influencing the Decisions of Psychiatric Patients: An Ethical Analysis. 275–279 (Ethics) Bolotaulo NI (see IsHak WW et al.). 138–150 (Review) Bolotaulo NI (see Ugochukwu C et al.). 1–17 (Review)
Cochran DM, Fallon D, Hill M, Frazier JA. The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings. 219–247 (Review) Coverdale J (see Blumenthal-Barby JS et al.). 275–279 (Ethics) Czerniak SM, Sikoglu EM, King JA, Kennedy DN, Mick E, Frazier J, Moore CM. Areas of the Brain Modulated by Single-Dose Methylphenidate Treatment in Youth with ADHD During Task-Based fMRI: A Systematic Review. 151–162 (Review)
D Danzer G. Helping Adolescents Just Say No to Drugs: A Multidimensional Family Therapeutic Approach. 175–180 (Perspectives) Davies F (see Chudleigh C et al.). 163–174 (Clinical Challenge) de Jonghe F (see de Maat S et al.). 107–137 (Review) de Kraker R (see de Maat S et al.). 107–137 (Review) de Leon-Martinez V (see Mendez-Bustos P et al.). 281–295 (Review) de Maat S, de Jonghe F, de Kraker R, Leichsenring F, Abbass A, Luyten P, Barber JP, Van R, Dekker J. The Current State of the Empirical Evidence for Psychoanalysis: A Meta-analytic Approach. 107–137 (Review) Dekker J (see de Maat S et al.). 107–137 (Review) Delaloye S (see IsHak WW et al.). 138–150 (Review) Delaloye S (see Ugochukwu C et al.). 1–17 (Review) Desseilles M, Witte J, Chang TE, Iovieno N, Dording C, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Massachusetts General Hospital SAFER Criteria for Clinical Trials and Research. 269–274 (Psychopharmacology) Dording C (see Desseilles M et al.). 269–274 (Psychopharmacology)
E Elbau I (see IsHak WW et al.). 138–150 (Review) Epstein LD (see Pollastri AR et al.). 188–199 (Perspectives)
F C Casher MI. ‘‘There’s no such thing as a patient’’: Reflections on the Significance of the Work of D. W. Winnicott for Modern Inpatient Psychiatric Treatment. 181–187 (Perspectives) Cassmassi B (see IsHak WW et al.). 138–150 (Review) Cather C (see Greene DI et al.). 259–268 (Clinical Challenge) Chang TE (see Desseilles M et al.). 269–274 (Psychopharmacology) Charrow AP (see Betancourt TS et al.). 70–91 (Review) Chu JA (see Biswas J et al.). 41–51 (Clinical Challenge) Chudleigh C, Kozlowska K, Kothur K, Davies F, Baxter H, Landini A, Hazell P, Baslet G. Managing Non-epileptic Seizures and Psychogenic Dystonia in an Adolescent Girl with Preterm Brain Injury. 163–174 (Clinical Challenge) January/February, pp. 1–57; March/April, pp. 59–105; May/June, pp. 107– 174; July/August, 175–218; September/October, pp. 219–280; November/ December, 281–350.
Fallon D (see Cochran DM et al.). 219–247 (Review) Fava M (see Desseilles M et al.). 269–274 (Psychopharmacology) Frazier J (see Czerniak SM et al.). 151–162 (Review) Frazier JA (see Cochran DM et al.). 219–247 (Review) Freedman JL, Gutheil TG. Sudden Discovery of a Previous Nonclinical Relationship with a Potential Patient: Implications for Subsequent Psychiatric Treatment. 102–105 (Ethics) Freeman MP (see Desseilles M et al.). 269–274 (Psychopharmacology)
G Gambino M. Erving Goffman’s Asylums and Institutional Culture in the Mid-twentieth-century United States. 52–57 (History) Garvey T (see Ugochukwu C et al.). 1–17 (Review) Greene DI, Spencer AE, Pridgen BC, Cather C, Ablon S. Evolving Illness, Shifting Perspectives: Childhood Psychosis Through the
Copyright @ 2013 President and Fellows of Harvard College. Unauthorized reproduction of this article is prohibited.
Lenses of Family Therapy and Individual Therapy. 259–268 (Clinical Challenge) Grenyer BFS (see Bailey RC et al.). 248–258 (Review) Gutheil TG (see Biswas J et al.). 41–51 (Clinical Challenge) Gutheil TG (see Freedman JL et al.). 102–105 (Ethics)
H Ha K (see IsHak WW et al.). 138–150 (Review) Hazell P (see Chudleigh C et al.). 163–174 (Clinical Challenge) Heath GH (see Pollastri AR et al.). 188–199 (Perspectives) Hill M (see Cochran DM et al.). 219–247 (Review)
I Iovieno N (see Desseilles M et al.). 269–274 (Psychopharmacology) IsHak WW (see Ugochukwu C et al.). 1–17 (Review)
IsHak WW, Elbau I, Ismail A, Delaloye S, Ha K, Bolotaulo NI, Nashawati R, Cassmassi B, Wang C. Quality of Life in Borderline Personality Disorder. 138–150 (Review) Ismail A (see IsHak WW et al.). 138–150 (Review)
J Johnson RA, Barrett MS, Sisti DA. The Ethical Boundaries of Patient and Advocate Influence on DSM-5. 334–344 (Perspectives) Juster R-P (see Bizik G et al.). 296–313 (Review)
K
Mehrmann C, Karmacharya R. Principles and Neurobiological Correlates of Concentrative, Diffuse, and Insight Meditation. 205–218 (Neurobiology) Mendez-Bustos P, de Leon-Martinez V, Miret M, Baca-Garcia E, Lopez-Castroman J. Suicide Reattempters: A Systematic Review. 281–295 (Review) Meyers-Ohki SE (see Betancourt TS et al.). 70–91 (Review) Mick E (see Czerniak SM et al.). 151–162 (Review) Miller M (see Uchida M et al.). 92–101 (Clinical Challenge) Miret M (see Mendez-Bustos P et al.). 281–295 (Review) Mischoulon D (see Desseilles M et al.). 269–274 (Psychopharmacology) Moore CM (see Czerniak SM et al.). 151–162 (Review)
N Nashawati R (see IsHak WW et al.). 138–150 (Review) Nijjar R (see Bizik G et al.). 296–313 (Review) Nyer M (see Desseilles M et al.). 269–274 (Psychopharmacology)
O Osser DN, Roudsari MJ, Manschreck T. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Schizophrenia. 18–40 (Perspectives)
P Perez DL (see Biswas J et al.). 41–51 (Clinical Challenge) Pi S (see Ugochukwu C et al.). 1–17 (Review) Picard M (see Bizik G et al.). 296–313 (Review) Pollastri AR, Epstein LD, Heath GH, Ablon JS. The Collaborative Problem Solving Approach: Outcomes Across Settings. 188– 199 (Perspectives) Pridgen BC (see Greene DI et al.). 259–268 (Clinical Challenge)
Karmacharya R (see Mehrmann C et al.). 205–218 (Neurobiology) Kennedy DN (see Czerniak SM et al.). 151–162 (Review) King JA (see Czerniak SM et al.). 151–162 (Review) Kothur K (see Chudleigh C et al.). 163–174 (Clinical Challenge) Kozlowska K (see Chudleigh C et al.). 163–174 (Clinical Challenge) Kozlowska K. Stress, Distress, and Bodytalk: Co-constructing Formulations with Patients Who Present with Somatic Symptoms. 314–333 (Perspectives) Krieger H (see Blumenthal-Barby JS et al.). 275–279 (Ethics) Kumar N (see Ugochukwu C et al.). 1–17 (Review)
Ravven S, Bader C, Azar A, Rudolph JL. Depressive Symptoms After CABG Surgery: A Meta-analysis. 59–69 (Review) Raz M. The Deprivation Riots: Psychiatry as Politics in the 1960s. 345–350 (History) Rigter H (see Liddle H et al.). 200–204 (Substance Abuse) Roudsari MJ (see Osser DN et al.). 18–40 (Perspectives) Rudolph JL (see Ravven S et al.). 59–69 (Review)
L
S
Landini A (see Chudleigh C et al.). 163–174 (Clinical Challenge) Leichsenring F (see de Maat S et al.). 107–137 (Review) Liddle H, Rigter H. How Developmental Research and Contextual Theory Drive Clinical Work with Adolescents with Addiction. 200–204 (Substance Abuse) Lopez-Castroman J (see Mendez-Bustos P et al.). 281–295 (Review) Lupien SJ (see) Bizik G et al.). 296–313 (Review) Luyten P (see de Maat S et al.). 107–137 (Review)
M Manschreck T (see Osser DN et al.). 18–40 (Perspectives) McCullough LB (see Blumenthal-Barby JS et al.). 275–279 (Ethics) McEwen BS (see) Bizik G et al.). 296–313 (Review)
R
Schmertz SK (see Uchida M et al.). 92–101 (Clinical Challenge) Sikoglu EM (see Czerniak SM et al.). 151–162 (Review) Sisti DA (see Johnson RA et al.). 334–344 (Perspectives) Spencer AE (see Greene DI et al.). 259–268 (Clinical Challenge)
T Tol WA (see Betancourt TS et al.). 70–91 (Review) Tourjman V (see Bizik G et al.). 296–313 (Review)
U Uchida M, Schmertz SK, Miller M, Yeung A. AVietnam War Veteran with Posttraumatic Stress Disorder, Status–Post-Myocardial
Copyright @ 2013 President and Fellows of Harvard College. Unauthorized reproduction of this article is prohibited.
Infarction, in Therapy with an Asian Therapist. 92–101 (Clinical Challenge) Ugochukwu C, Bagot KS, Delaloye S, Pi S, Vien L, Garvey T, Bolotaulo NI, Kumar N, IsHak WW. The Importance of Quality of Life in Patients with Alcohol Abuse and Dependence. 1–17 (Review)
V Van R (see de Maat S et al.). 107–137 (Review)
Vien L (see Ugochukwu C et al.). 1–17 (Review)
W Wang C (see IsHak WW et al.). 138–150 (Review) Witte J (see Desseilles M et al.). 269–274 (Psychopharmacology)
Y Yeung A (see Uchida M et al.). 92–101 (Clinical Challenge)
Copyright @ 2013 President and Fellows of Harvard College. Unauthorized reproduction of this article is prohibited.
B Baca-Garcia E (see Mendez-Bustos P et al.). 281–295 (Review) Bader C (see Ravven S et al.). 59–69 (Review) Bagot KS (see Ugochukwu C et al.). 1–17 (Review) Bailey RC, Grenyer BFS. Burden and Support Needs of Carers of Persons with Borderline Personality Disorder: A Systematic Review. 248–258 (Review) Barber JP (see de Maat S et al.). 107–137 (Review) Barrett MS (see Johnson RA et al.). 334–344 (Perspectives) Baslet G (see Chudleigh C et al.). 163–174 (Clinical Challenge) Baxter H (see Chudleigh C et al.). 163–174 (Clinical Challenge) Betancourt TS, Meyers-Ohki SE, Charrow AP, Tol WA. Interventions for Children Affected by War: An Ecological Perspective on Psychosocial Support and Mental Health Care. 70–91 (Review) Biswas J, Chu JA, Perez DL, Gutheil TG. From the Neuropsychiatric to the Analytic: Three Perspectives on Dissociative Identity Disorder. 41–51 (Clinical Challenge) Bizik G, Picard M, Nijjar R, Tourjman V, McEwen BS, Lupien SJ, Juster R-P. Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses. 296–313 (Review) Blumenthal-Barby JS, McCullough LB, Krieger H, Coverdale J. Methods of Influencing the Decisions of Psychiatric Patients: An Ethical Analysis. 275–279 (Ethics) Bolotaulo NI (see IsHak WW et al.). 138–150 (Review) Bolotaulo NI (see Ugochukwu C et al.). 1–17 (Review)
Cochran DM, Fallon D, Hill M, Frazier JA. The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings. 219–247 (Review) Coverdale J (see Blumenthal-Barby JS et al.). 275–279 (Ethics) Czerniak SM, Sikoglu EM, King JA, Kennedy DN, Mick E, Frazier J, Moore CM. Areas of the Brain Modulated by Single-Dose Methylphenidate Treatment in Youth with ADHD During Task-Based fMRI: A Systematic Review. 151–162 (Review)
D Danzer G. Helping Adolescents Just Say No to Drugs: A Multidimensional Family Therapeutic Approach. 175–180 (Perspectives) Davies F (see Chudleigh C et al.). 163–174 (Clinical Challenge) de Jonghe F (see de Maat S et al.). 107–137 (Review) de Kraker R (see de Maat S et al.). 107–137 (Review) de Leon-Martinez V (see Mendez-Bustos P et al.). 281–295 (Review) de Maat S, de Jonghe F, de Kraker R, Leichsenring F, Abbass A, Luyten P, Barber JP, Van R, Dekker J. The Current State of the Empirical Evidence for Psychoanalysis: A Meta-analytic Approach. 107–137 (Review) Dekker J (see de Maat S et al.). 107–137 (Review) Delaloye S (see IsHak WW et al.). 138–150 (Review) Delaloye S (see Ugochukwu C et al.). 1–17 (Review) Desseilles M, Witte J, Chang TE, Iovieno N, Dording C, Ashih H, Nyer M, Freeman MP, Fava M, Mischoulon D. Massachusetts General Hospital SAFER Criteria for Clinical Trials and Research. 269–274 (Psychopharmacology) Dording C (see Desseilles M et al.). 269–274 (Psychopharmacology)
E Elbau I (see IsHak WW et al.). 138–150 (Review) Epstein LD (see Pollastri AR et al.). 188–199 (Perspectives)
F C Casher MI. ‘‘There’s no such thing as a patient’’: Reflections on the Significance of the Work of D. W. Winnicott for Modern Inpatient Psychiatric Treatment. 181–187 (Perspectives) Cassmassi B (see IsHak WW et al.). 138–150 (Review) Cather C (see Greene DI et al.). 259–268 (Clinical Challenge) Chang TE (see Desseilles M et al.). 269–274 (Psychopharmacology) Charrow AP (see Betancourt TS et al.). 70–91 (Review) Chu JA (see Biswas J et al.). 41–51 (Clinical Challenge) Chudleigh C, Kozlowska K, Kothur K, Davies F, Baxter H, Landini A, Hazell P, Baslet G. Managing Non-epileptic Seizures and Psychogenic Dystonia in an Adolescent Girl with Preterm Brain Injury. 163–174 (Clinical Challenge) January/February, pp. 1–57; March/April, pp. 59–105; May/June, pp. 107– 174; July/August, 175–218; September/October, pp. 219–280; November/ December, 281–350.
Fallon D (see Cochran DM et al.). 219–247 (Review) Fava M (see Desseilles M et al.). 269–274 (Psychopharmacology) Frazier J (see Czerniak SM et al.). 151–162 (Review) Frazier JA (see Cochran DM et al.). 219–247 (Review) Freedman JL, Gutheil TG. Sudden Discovery of a Previous Nonclinical Relationship with a Potential Patient: Implications for Subsequent Psychiatric Treatment. 102–105 (Ethics) Freeman MP (see Desseilles M et al.). 269–274 (Psychopharmacology)
G Gambino M. Erving Goffman’s Asylums and Institutional Culture in the Mid-twentieth-century United States. 52–57 (History) Garvey T (see Ugochukwu C et al.). 1–17 (Review) Greene DI, Spencer AE, Pridgen BC, Cather C, Ablon S. Evolving Illness, Shifting Perspectives: Childhood Psychosis Through the
Copyright @ 2013 President and Fellows of Harvard College. Unauthorized reproduction of this article is prohibited.
Lenses of Family Therapy and Individual Therapy. 259–268 (Clinical Challenge) Grenyer BFS (see Bailey RC et al.). 248–258 (Review) Gutheil TG (see Biswas J et al.). 41–51 (Clinical Challenge) Gutheil TG (see Freedman JL et al.). 102–105 (Ethics)
H Ha K (see IsHak WW et al.). 138–150 (Review) Hazell P (see Chudleigh C et al.). 163–174 (Clinical Challenge) Heath GH (see Pollastri AR et al.). 188–199 (Perspectives) Hill M (see Cochran DM et al.). 219–247 (Review)
I Iovieno N (see Desseilles M et al.). 269–274 (Psychopharmacology) IsHak WW (see Ugochukwu C et al.). 1–17 (Review)
IsHak WW, Elbau I, Ismail A, Delaloye S, Ha K, Bolotaulo NI, Nashawati R, Cassmassi B, Wang C. Quality of Life in Borderline Personality Disorder. 138–150 (Review) Ismail A (see IsHak WW et al.). 138–150 (Review)
J Johnson RA, Barrett MS, Sisti DA. The Ethical Boundaries of Patient and Advocate Influence on DSM-5. 334–344 (Perspectives) Juster R-P (see Bizik G et al.). 296–313 (Review)
K
Mehrmann C, Karmacharya R. Principles and Neurobiological Correlates of Concentrative, Diffuse, and Insight Meditation. 205–218 (Neurobiology) Mendez-Bustos P, de Leon-Martinez V, Miret M, Baca-Garcia E, Lopez-Castroman J. Suicide Reattempters: A Systematic Review. 281–295 (Review) Meyers-Ohki SE (see Betancourt TS et al.). 70–91 (Review) Mick E (see Czerniak SM et al.). 151–162 (Review) Miller M (see Uchida M et al.). 92–101 (Clinical Challenge) Miret M (see Mendez-Bustos P et al.). 281–295 (Review) Mischoulon D (see Desseilles M et al.). 269–274 (Psychopharmacology) Moore CM (see Czerniak SM et al.). 151–162 (Review)
N Nashawati R (see IsHak WW et al.). 138–150 (Review) Nijjar R (see Bizik G et al.). 296–313 (Review) Nyer M (see Desseilles M et al.). 269–274 (Psychopharmacology)
O Osser DN, Roudsari MJ, Manschreck T. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Schizophrenia. 18–40 (Perspectives)
P Perez DL (see Biswas J et al.). 41–51 (Clinical Challenge) Pi S (see Ugochukwu C et al.). 1–17 (Review) Picard M (see Bizik G et al.). 296–313 (Review) Pollastri AR, Epstein LD, Heath GH, Ablon JS. The Collaborative Problem Solving Approach: Outcomes Across Settings. 188– 199 (Perspectives) Pridgen BC (see Greene DI et al.). 259–268 (Clinical Challenge)
Karmacharya R (see Mehrmann C et al.). 205–218 (Neurobiology) Kennedy DN (see Czerniak SM et al.). 151–162 (Review) King JA (see Czerniak SM et al.). 151–162 (Review) Kothur K (see Chudleigh C et al.). 163–174 (Clinical Challenge) Kozlowska K (see Chudleigh C et al.). 163–174 (Clinical Challenge) Kozlowska K. Stress, Distress, and Bodytalk: Co-constructing Formulations with Patients Who Present with Somatic Symptoms. 314–333 (Perspectives) Krieger H (see Blumenthal-Barby JS et al.). 275–279 (Ethics) Kumar N (see Ugochukwu C et al.). 1–17 (Review)
Ravven S, Bader C, Azar A, Rudolph JL. Depressive Symptoms After CABG Surgery: A Meta-analysis. 59–69 (Review) Raz M. The Deprivation Riots: Psychiatry as Politics in the 1960s. 345–350 (History) Rigter H (see Liddle H et al.). 200–204 (Substance Abuse) Roudsari MJ (see Osser DN et al.). 18–40 (Perspectives) Rudolph JL (see Ravven S et al.). 59–69 (Review)
L
S
Landini A (see Chudleigh C et al.). 163–174 (Clinical Challenge) Leichsenring F (see de Maat S et al.). 107–137 (Review) Liddle H, Rigter H. How Developmental Research and Contextual Theory Drive Clinical Work with Adolescents with Addiction. 200–204 (Substance Abuse) Lopez-Castroman J (see Mendez-Bustos P et al.). 281–295 (Review) Lupien SJ (see) Bizik G et al.). 296–313 (Review) Luyten P (see de Maat S et al.). 107–137 (Review)
M Manschreck T (see Osser DN et al.). 18–40 (Perspectives) McCullough LB (see Blumenthal-Barby JS et al.). 275–279 (Ethics) McEwen BS (see) Bizik G et al.). 296–313 (Review)
R
Schmertz SK (see Uchida M et al.). 92–101 (Clinical Challenge) Sikoglu EM (see Czerniak SM et al.). 151–162 (Review) Sisti DA (see Johnson RA et al.). 334–344 (Perspectives) Spencer AE (see Greene DI et al.). 259–268 (Clinical Challenge)
T Tol WA (see Betancourt TS et al.). 70–91 (Review) Tourjman V (see Bizik G et al.). 296–313 (Review)
U Uchida M, Schmertz SK, Miller M, Yeung A. AVietnam War Veteran with Posttraumatic Stress Disorder, Status–Post-Myocardial
Copyright @ 2013 President and Fellows of Harvard College. Unauthorized reproduction of this article is prohibited.
Infarction, in Therapy with an Asian Therapist. 92–101 (Clinical Challenge) Ugochukwu C, Bagot KS, Delaloye S, Pi S, Vien L, Garvey T, Bolotaulo NI, Kumar N, IsHak WW. The Importance of Quality of Life in Patients with Alcohol Abuse and Dependence. 1–17 (Review)
V Van R (see de Maat S et al.). 107–137 (Review)
Vien L (see Ugochukwu C et al.). 1–17 (Review)
W Wang C (see IsHak WW et al.). 138–150 (Review) Witte J (see Desseilles M et al.). 269–274 (Psychopharmacology)
Y Yeung A (see Uchida M et al.). 92–101 (Clinical Challenge)
Copyright @ 2013 President and Fellows of Harvard College. Unauthorized reproduction of this article is prohibited.
